🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
End-of-dose fluctuations e. g. wearing-off are defined as a recurrence of m...
Status
Completed
Location
Teva Investigational Sites
Start Date
2014-01
Trial ID
NCT02384512
Treatments Being Tested
To evaluate the efficacy of a fixed dose of Azilect® (1 mg/day) vs placebo ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01268891
The purpose of this study is to fulfil regulatory requirements for registra...
Status
Completed
Location
CN001
Start Date
2012-05
Trial ID
NCT01652313
Treatments Being Tested
Among the psychiatric symptoms observed in the premotor phase of Parkinson'...
Status
Unknown
Location
CHU Clermont-Ferrand
Start Date
2013-06
Trial ID
NCT01765257
The rationale for conducting this study is to evaluate the efficacy, tolera...
Status
Completed
Location
CN015
Start Date
2011-12
Trial ID
NCT01479530
This is a 24-week, multicenter, randomized, double-blind, placebo-controlle...
Status
Completed
Location
Teva Investigational Site 036
Start Date
2012-11
Trial ID
NCT01723228
Treatments Being Tested
This study is designed to evaluate the pharmacokinetics of rasagiline in he...
Status
Completed
Location
Teva Investigational Site 10738
Start Date
2013-06
Trial ID
NCT01879748
Treatments Being Tested
HNC364 is a new pro-drug of rasagiline as a long-acting injection for deep ...
Status
Active Not Recruiting
Location
Frontage Clinical Services, Inc.
Start Date
2026-05-08
Trial ID
NCT06798519
Treatments Being Tested
The main objective of this study is to evaluate the effect of Azilect® on s...
Status
Completed
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01032486
Treatments Being Tested
The primary purpose of this extension study is to assess the long-term safe...
Status
Terminated
Location
Multiple Locations
Start Date
2010-11-18
Trial ID
NCT01215227
Treatments Being Tested